Triethylamine → (S)-tert-butyl 1-(4-(benzo[d]oxazol-2-yl)piperazin-1-yl)-1-oxo-3-(thiophen-2-yl)propan-2-ylcarbamate
反応式
[N:1]1([C:7]2[O:8][C:9]3[CH:15]=[CH:14][CH:13]=[CH:12][C:10]=3[N:11]=2)[CH2:6][CH2:5]C[CH2:3][CH2:2]1.O.O[N:18]1C2C=CC=CC=2N=N1.[C:27]([NH:34][C@H:35]([C:42]([OH:44])=O)[CH2:36][C:37]1[S:38][CH:39]=[CH:40][CH:41]=1)([O:29][C:30]([CH3:33])([CH3:32])[CH3:31])=[O:28].C(N(CC)CC)C.Cl.CN(C)CCCN=C=NCC>ClCCl.C(Cl)(Cl)Cl>[O:8]1[C:9]2[CH:15]=[CH:14][CH:13]=[CH:12][C:10]=2[N:11]=[C:7]1[N:1]1[CH2:6][CH2:5][N:18]([C:42](=[O:44])[C@@H:35]([NH:34][C:27](=[O:28])[O:29][C:30]([CH3:33])([CH3:32])[CH3:31])[CH2:36][C:37]2[S:38][CH:39]=[CH:40][CH:41]=2)[CH2:3][CH2:2]1参加物
反応物 5
生成物 1
試薬・触媒・溶媒 2
実験手順
2-Piperidino-1,3-benzoxazole (203.6 mgs, 1.00 mmol), N-hydroxybenzotriazole hydrate (138.2 mg, 1.02 mmol) and Boc-β-(2-thienyl)-L-alanine (272.6 mgs, 1.00 mmol) in dichloromethane (10 mL) was cooled in an ice bath, then treated with triethylamine (0.30 mL, 2.15 mmol) and 1-[3-dimethylaminopropyl]-3-ethyl carbodiimide hydrochloride (199.5 mg, 1.04 mmol). The resulting mixture was stirred overnight at room temperature. After 18 h, the resulting mixture was diluted with chloroform and washed with water. The organic layer was dried over sodium sulfate, filtered and concentrated to a residue. The residue was purified by flash column chromatography, eluting with 3% methanol in chloroform to yield (S)-tert-butyl 1-(4-(benzo[d]oxazol-2-yl)piperazin-1-yl)-1-oxo-3-(thiophen-2-yl)propan-2-ylcarbamate as a colorless glass.
後処理
- waitAfter 18 h
- washwashed with water
- dry with materialThe organic layer was dried over sodium sulfate
- filtrationfiltered
- concentrationconcentrated to a residue
- customThe residue was purified by flash column chromatography
- washeluting with 3% methanol in chloroform
出典と根拠
- ORDレコード
- ord-11e2ceacdd0542b1925fef49ef7b9f5c
- 出典データセット
- uspto-grants-2013_07
- 特許番号
- US08481547B2
反応ノート
読み込み中…